Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 27

1.

Comparison of Digital Rectal Examination and Serum Prostate Specific Antigen in the Early Detection of Prostate Cancer: Results of a Multicenter Clinical Trial of 6,630 Men.

Catalona WJ, Richie JP, Ahmann FR, Hudson MA, Scardino PT, Flanigan RC, DeKernion JB, Ratliff TL, Kavoussi LR, Dalkin BL, Waters WB, MacFarlane MT, Southwick PC.

J Urol. 2017 Feb;197(2S):S200-S207. doi: 10.1016/j.juro.2016.10.073. Epub 2016 Dec 22.

PMID:
28012755
2.

Wrong to be Right: Margin Laterality is an Independent Predictor of Biochemical Failure After Radical Prostatectomy.

Kang JJ, Reiter RE, Kummer N, DeKernion J, Steinberg ML, King CR.

Am J Clin Oncol. 2018 Jan;41(1):1-5. doi: 10.1097/COC.0000000000000216.

PMID:
26237192
3.

Jean B. DeKernion--a gentleman chairman. Interview by Arnold I. Chin.

DeKernion JB.

Urology. 2012 Aug;80(2):244-6. doi: 10.1016/j.urology.2012.05.022. No abstract available.

PMID:
22857744
4.

Urinary retention after orthotopic neobladder substitution in females.

Finley DS, Lee U, McDonough D, Raz S, deKernion J.

J Urol. 2011 Oct;186(4):1364-9. doi: 10.1016/j.juro.2011.05.069.

PMID:
21855940
5.

Legends in urology.

deKernion JB.

Can J Urol. 2011 Apr;18(2):5582-4. No abstract available.

6.

In vivo imaging of intraprostatic-specific gene transcription by PET.

Pouliot F, Karanikolas BD, Johnson M, Sato M, Priceman SJ, Stout D, Sohn J, Satyamurthy N, deKernion JB, Wu L.

J Nucl Med. 2011 May;52(5):784-91. doi: 10.2967/jnumed.110.084582. Epub 2011 Apr 15.

7.

Ultrasound-based combination therapy: potential in urologic cancer.

Finley DS, Pouliot F, Shuch B, Chin A, Pantuck A, Dekernion JB, Belldegrun AS.

Expert Rev Anticancer Ther. 2011 Jan;11(1):107-13. doi: 10.1586/era.10.174. Review.

PMID:
21166515
8.

Immunological therapy in urological malignancy: novel combination strategies.

Finley DS, Pouliot F, Chin AI, Shuch B, Pantuck AJ, Belldegrun AS, Dekernion JB.

Int J Urol. 2011 Feb;18(2):94-101. doi: 10.1111/j.1442-2042.2010.02664.x. Epub 2010 Nov 12. Review.

9.

Cancer-specific survival outcomes among patients treated during the cytokine era of kidney cancer (1989-2005): a benchmark for emerging targeted cancer therapies.

Belldegrun AS, Klatte T, Shuch B, LaRochelle JC, Miller DC, Said JW, Riggs SB, Zomorodian N, Kabbinavar FF, Dekernion JB, Pantuck AJ.

Cancer. 2008 Nov 1;113(9):2457-63. doi: 10.1002/cncr.23851.

10.

Na,K-adenosine triphosphatase alpha1-subunit predicts survival of renal clear cell carcinoma.

Seligson DB, Rajasekaran SA, Yu H, Liu X, Eeva M, Tze S, Ball W Jr, Horvath S, deKernion JB, Rajasekaran AK.

J Urol. 2008 Jan;179(1):338-45. Epub 2007 Nov 19.

PMID:
18006011
11.
12.

Society of Urologic Oncology: Whitmore lecture.

deKernion JB.

Urol Oncol. 2006 Jul-Aug;24(4):318-21. No abstract available.

PMID:
16818184
13.

Reexamination of current staging for renal cell carcinoma.

deKernion JB.

J Urol. 2005 Mar;173(3):680. No abstract available.

PMID:
15711241
14.

Glutathione S-transferase P1 Ile105Val polymorphism, cigarette smoking and prostate cancer.

Mao GE, Morris G, Lu QY, Cao W, Reuter VE, Cordon-Cardo C, Dalbagni G, Scher HI, deKernion JB, Zhang ZF.

Cancer Detect Prev. 2004;28(5):368-74.

PMID:
15542263
15.

Dominant B cell epitope from NY-ESO-1 recognized by sera from a wide spectrum of cancer patients: implications as a potential biomarker.

Zeng G, Aldridge ME, Wang Y, Pantuck AJ, Wang AY, Liu YX, Han Y, Yuan YH, Robbins PF, Dubinett SM, deKernion JB, Belldegrun AS.

Int J Cancer. 2005 Mar 20;114(2):268-73.

16.

Predictors of metastatic disease in men with biochemical failure following radical prostatectomy.

Okotie OT, Aronson WJ, Wieder JA, Liao Y, Dorey F, DeKERNION JB, Freedland SJ.

J Urol. 2004 Jun;171(6 Pt 1):2260-4.

PMID:
15126798
17.

Decreased retinoid X receptor-alpha protein expression in basal cells occurs in the early stage of human prostate cancer development.

Mao GE, Reuter VE, Cordon-Cardo C, Dalbagni G, Scher HI, DeKernion JB, Zhang ZF, Rao J.

Cancer Epidemiol Biomarkers Prev. 2004 Mar;13(3):383-90.

18.

Renal cell carcinoma with tumor thrombus extension: biology, role of nephrectomy and response to immunotherapy.

Zisman A, Wieder JA, Pantuck AJ, Chao DH, Dorey F, Said JW, Gitlitz BJ, deKernion JB, Figlin RA, Belldegrun AS.

J Urol. 2003 Mar;169(3):909-16.

PMID:
12576811
19.

Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma.

Zisman A, Pantuck AJ, Wieder J, Chao DH, Dorey F, Said JW, deKernion JB, Figlin RA, Belldegrun AS.

J Clin Oncol. 2002 Dec 1;20(23):4559-66.

PMID:
12454113
20.

Supplemental Content

Loading ...
Support Center